{"id":"W2984886575","doi":"10.1136/ijgc-2019-000623","title":"Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety","year":2019,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"Foundation Medicine; National Institute for Health and Care Research; Wellcome Trust; Clovis Oncology; University College London; Wellcome","keywords":"Medicine; PARP inhibitor; Ovarian cancer; Poly ADP ribose polymerase; Polymerase; Cancer research; BRCA mutation; Olaparib; Oncology; Internal medicine; Pharmacology; Cancer; Gene; Genetics; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002698559,0.0002422508,0.0005405204,0.0002100476,0.00005494872,0.00002898784,0.0002508995,0.0001485903,0.0008998582],"category_scores_gemma":[0.00007969937,0.0001498155,0.0001133439,0.0002260334,0.0002120422,0.0003075237,0.00004644789,0.0006199948,0.000004348846],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007662358,"about_ca_system_score_gemma":0.0004489305,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008139394,"about_ca_topic_score_gemma":0.0002186177,"domain_scores_codex":[0.9977779,0.0001762797,0.0005938946,0.0003108094,0.0009015301,0.0002396309],"domain_scores_gemma":[0.9980627,0.0002361203,0.0008258251,0.0002001335,0.0005217607,0.0001534684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0545809,0.002386562,0.8641058,0.00003041678,0.0008223455,0.0001824731,0.0004590999,0.001307533,0.03964625,0.001294715,0.0003456565,0.03483832],"study_design_scores_gemma":[0.02081052,0.002392309,0.9086719,0.0005500388,0.00004704422,0.00004846739,0.00004432963,0.00009098097,0.06602048,0.0002435524,0.0008810579,0.0001993565],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900948,0.0001868034,0.00002781573,0.007276462,0.001479291,0.0004785351,0.0002242326,0.00001097015,0.0002210279],"genre_scores_gemma":[0.9959805,0.0004274439,0.0002435002,0.002783103,0.0004171368,0.00001694127,0.00001215448,0.00002664414,0.00009259197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04456613,"threshold_uncertainty_score":0.9852816,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01021651370825646,"score_gpt":0.2947875185163555,"score_spread":0.284571004808099,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}